• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影响肯尼亚卫生部主导的私人药品零售商疟疾项目实施的因素。

Factors influencing implementation of the Ministry of Health-led private medicine retailer programmes on malaria in Kenya.

机构信息

Life & Peace Institute, Somalia Programme, Nairobi, Kenya.

出版信息

BMC Public Health. 2010 Feb 24;10:93. doi: 10.1186/1471-2458-10-93.

DOI:10.1186/1471-2458-10-93
PMID:20181234
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2837856/
Abstract

BACKGROUND

Kenya has experienced a number of retail sector initiatives aimed at improving access to antimalarial medicines. This study explored stakeholders' perceptions of the role of private medicine retailers (PMRs), the value and feasibility of programme goals, perceived programme impact, factors influencing implementation and recommendations in three districts of Kenya.

METHODS

This study was part of a larger evaluation of PMR programmes, including quantitative and qualitative components. The qualitative research was conducted to assess implementation processes and actors' experiences in the programmes, through focus group discussions with trained PMRs and mothers of children under five years, and in-depth interviews with programme managers, trainers and co-trainers.

RESULTS

PMRs were perceived to provide rapid cheap treatment for non-serious conditions and used as a deliberate and continuously evaluated choice between different treatment sources. All stakeholders supported programme goals and most PMRs described increased customer satisfaction, more rational purchasing of medicine stock and increased medicine sales after participation. Factors undermining programme implementation included a lack of MoH resources to train and monitor large numbers of PMRs, the relative instability of outlets, medicines stocked and retail personnel, the large number of proprietary brands and financial challenges to retailers in stocking antimalarial medicines, and their customers in buying them. Unambiguous national support and a broad range of strategies are important to strengthen the feasibility of change in OTC antimalarial use.

CONCLUSIONS

Understanding the context and implementation processes of PMR programmes and the perspectives of key actors are critical to identifying measures to support their effective implementation. Financial barriers underlie many described challenges, with important implications for policies on subsidies in this sector. In spite of barriers to implementation, increased exposure to programme activities promoted trust and improved relationships between PMRs and their clients and trainers, strengthening feasibility of such interventions. Public information can strengthen PMR training programmes by engaging local communities and may facilitate performance monitoring of PMRs by their clients.

摘要

背景

肯尼亚已经实施了多项零售行业倡议,旨在改善抗疟药物的可及性。本研究探讨了利益攸关方对私营医药零售商(PMR)的作用、项目目标的价值和可行性、感知项目影响、影响实施的因素以及在肯尼亚三个地区的建议的看法。

方法

本研究是对 PMR 项目的更广泛评估的一部分,包括定量和定性部分。定性研究是通过与经过培训的 PMR 和五岁以下儿童的母亲进行焦点小组讨论,以及与方案管理人员、培训人员和共同培训人员进行深入访谈,评估方案的实施过程和参与者的经验。

结果

PMR 被认为可以快速廉价地治疗非严重疾病,并被视为在不同治疗来源之间的刻意和持续评估的选择。所有利益攸关方都支持项目目标,大多数 PMR 描述了客户满意度的提高、对药品库存的更理性采购以及参与后药品销售的增加。破坏项目实施的因素包括卫生部缺乏资源来培训和监测大量的 PMR、网点的相对不稳定、储存的药品和零售人员、大量的专利品牌以及零售商储存抗疟药物和客户购买这些药物的财务挑战。国家的明确支持和广泛的战略对于加强 OTC 抗疟药物使用变革的可行性至关重要。

结论

了解 PMR 项目的背景和实施过程以及关键行为者的观点,对于确定支持其有效实施的措施至关重要。财政障碍是许多描述的挑战的基础,对该部门的补贴政策有重要影响。尽管存在实施障碍,但增加对项目活动的接触促进了 PMR 与其客户和培训师之间的信任和关系的改善,从而增强了此类干预措施的可行性。公共信息可以通过吸引当地社区来加强 PMR 培训计划,并可能促进客户对 PMR 的绩效监测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e646/2837856/893ef9245dd7/1471-2458-10-93-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e646/2837856/893ef9245dd7/1471-2458-10-93-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e646/2837856/893ef9245dd7/1471-2458-10-93-1.jpg

相似文献

1
Factors influencing implementation of the Ministry of Health-led private medicine retailer programmes on malaria in Kenya.影响肯尼亚卫生部主导的私人药品零售商疟疾项目实施的因素。
BMC Public Health. 2010 Feb 24;10:93. doi: 10.1186/1471-2458-10-93.
2
Importance of strategic management in the implementation of private medicine retailer programmes: case studies from three districts in Kenya.战略管理在实施私立医疗机构零售商计划中的重要性:肯尼亚三个地区的案例研究。
BMC Health Serv Res. 2010 Jul 2;10 Suppl 1(Suppl 1):S7. doi: 10.1186/1472-6963-10-S1-S7.
3
Evaluating different dimensions of programme effectiveness for private medicine retailer malaria control interventions in Kenya.评估肯尼亚私人药品零售商疟疾控制干预措施在不同维度上的效果。
PLoS One. 2010 Jan 28;5(1):e8937. doi: 10.1371/journal.pone.0008937.
4
Use of over-the-counter malaria medicines in children and adults in three districts in Kenya: implications for private medicine retailer interventions.肯尼亚三个地区儿童和成人使用非处方抗疟药物情况:对私立药品零售商干预措施的启示
Malar J. 2007 May 10;6:57. doi: 10.1186/1475-2875-6-57.
5
Experience of healthcare personnel on Co-payment mechanism and the implications on its use in private drug outlets in Uganda.卫生保健人员对共付机制的经验及其在乌干达私人药店使用的影响。
PLoS One. 2024 May 17;19(5):e0297416. doi: 10.1371/journal.pone.0297416. eCollection 2024.
6
Accessibility, availability and affordability of anti-malarials in a rural district in Kenya after implementation of a national subsidy scheme.肯尼亚农村地区实施国家补贴计划后抗疟药物的可及性、可获得性和可负担性。
Malar J. 2011 Oct 26;10:316. doi: 10.1186/1475-2875-10-316.
7
Retail supply of malaria-related drugs in rural Tanzania: risks and opportunities.坦桑尼亚农村地区疟疾相关药物的零售供应:风险与机遇
Trop Med Int Health. 2004 Jun;9(6):655-63. doi: 10.1111/j.1365-3156.2004.01245.x.
8
Impact of ministry of health interventions on private medicine retailer knowledge and practices on anti-malarial treatment in Kenya.肯尼亚卫生部干预措施对私立药品零售商疟疾治疗知识及实践的影响。
Am J Trop Med Hyg. 2009 Jun;80(6):905-13.
9
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
10
A cross-sectional study of the availability and price of anti-malarial medicines and malaria rapid diagnostic tests in private sector retail drug outlets in rural Western Kenya, 2013.2013年肯尼亚西部农村地区私营零售药店抗疟药品及疟疾快速诊断检测试剂的可及性与价格横断面研究
Malar J. 2016 Jul 12;15(1):359. doi: 10.1186/s12936-016-1404-5.

引用本文的文献

1
Perceptions and drivers of healthcare provider and drug dispenser practices for the treatment of malaria in pregnancy in the context of multiple first-line therapies in western Kenya: a qualitative study.在肯尼亚西部多种一线疗法背景下,针对孕妇疟疾治疗的医疗保健提供者和药物发放人员的实践观念和驱动因素:一项定性研究。
Malar J. 2023 Sep 14;22(1):274. doi: 10.1186/s12936-023-04698-w.
2
An assessment of the malaria-related knowledge and practices of Tanzania's drug retailers: exploring the impact of drug store accreditation.坦桑尼亚药品零售商的疟疾相关知识与实践评估:探究药店认证的影响
BMC Health Serv Res. 2018 Mar 9;18(1):169. doi: 10.1186/s12913-018-2966-4.
3

本文引用的文献

1
Impact of ministry of health interventions on private medicine retailer knowledge and practices on anti-malarial treatment in Kenya.肯尼亚卫生部干预措施对私立药品零售商疟疾治疗知识及实践的影响。
Am J Trop Med Hyg. 2009 Jun;80(6):905-13.
2
Review: Provider practice and user behavior interventions to improve prompt and effective treatment of malaria: do we know what works?综述:改善疟疾及时有效治疗的医疗服务提供者实践与用户行为干预措施:我们知道哪些措施有效吗?
Am J Trop Med Hyg. 2009 Mar;80(3):326-35.
3
The terrain of health policy analysis in low and middle income countries: a review of published literature 1994-2007.
Engaging the private sector in malaria surveillance: a review of strategies and recommendations for elimination settings.
让私营部门参与疟疾监测:消除疟疾环境下的策略与建议综述
Malar J. 2017 Jun 14;16(1):252. doi: 10.1186/s12936-017-1901-1.
4
Evaluation of medicine retail outlets for sale of typhoid fever vaccine among adults in two urban and rural settings in western Kenya: a proof-of-concept study.肯尼亚西部两个城乡地区成人伤寒疫苗销售的药品零售网点评估:一项概念验证研究。
BMC Health Serv Res. 2016 Sep 29;16(1):527. doi: 10.1186/s12913-016-1788-5.
5
Access to artemisinin-combination therapy (ACT) and other anti-malarials: national policy and markets in Sierra Leone.青蒿素类复方疗法(ACT)及其他抗疟药物的获取途径:塞拉利昂的国家政策与市场。
PLoS One. 2012;7(10):e47733. doi: 10.1371/journal.pone.0047733. Epub 2012 Oct 25.
6
Accessibility, availability and affordability of anti-malarials in a rural district in Kenya after implementation of a national subsidy scheme.肯尼亚农村地区实施国家补贴计划后抗疟药物的可及性、可获得性和可负担性。
Malar J. 2011 Oct 26;10:316. doi: 10.1186/1475-2875-10-316.
低收入和中等收入国家卫生政策分析的领域:1994年至2007年已发表文献综述
Health Policy Plan. 2008 Sep;23(5):294-307. doi: 10.1093/heapol/czn019. Epub 2008 Jul 22.
4
Malaria treatment in the retail sector: knowledge and practices of drug sellers in rural Tanzania.零售部门的疟疾治疗:坦桑尼亚农村地区药品销售商的知识与做法
BMC Public Health. 2008 May 9;8:157. doi: 10.1186/1471-2458-8-157.
5
Medicine sellers and malaria treatment in sub-Saharan Africa: what do they do and how can their practice be improved?撒哈拉以南非洲地区的药品销售商与疟疾治疗:他们做些什么,以及如何改进他们的做法?
Am J Trop Med Hyg. 2007 Dec;77(6 Suppl):203-18.
6
Drug shop regulation and malaria treatment in Tanzania--why do shops break the rules, and does it matter?坦桑尼亚的药店监管与疟疾治疗——为何药店会违规,这有关系吗?
Health Policy Plan. 2007 Nov;22(6):393-403. doi: 10.1093/heapol/czm033. Epub 2007 Oct 4.
7
An in-depth study of patent medicine sellers' perspectives on malaria in a rural Nigerian community.对尼日利亚一个农村社区中药商对疟疾看法的深入研究。
Malar J. 2006 Nov 1;5:97. doi: 10.1186/1475-2875-5-97.
8
Prevention and treatment strategies used for the community management of childhood fever in Kampala, Uganda.乌干达坎帕拉用于儿童发热社区管理的预防和治疗策略。
Am J Trop Med Hyg. 2006 Jun;74(6):999-1007.
9
The cost-effectiveness of improving malaria home management: shopkeeper training in rural Kenya.改善疟疾家庭管理的成本效益:肯尼亚农村地区店主培训
Health Policy Plan. 2006 Jul;21(4):275-88. doi: 10.1093/heapol/czl011. Epub 2006 May 8.
10
The quality of sulphadoxine-pyrimethamine and amodiaquine products in the Kenyan retail sector.肯尼亚零售部门中磺胺多辛-乙胺嘧啶和阿莫地喹产品的质量。
J Clin Pharm Ther. 2005 Dec;30(6):559-65. doi: 10.1111/j.1365-2710.2005.00685.x.